Kirkiin: A New Toxic Type 2 Ribosome-Inactivating Protein from the Caudex of


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
22 01 2021
Historique:
received: 29 12 2020
revised: 18 01 2021
accepted: 19 01 2021
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 2 7 2021
Statut: epublish

Résumé

Ribosome-inactivating proteins (RIPs) are plant toxins that irreversibly damage ribosomes and other substrates, thus causing cell death. RIPs are classified in type 1 RIPs, single-chain enzymatic proteins, and type 2 RIPs, consisting of active A chains, similar to type 1 RIPs, linked to lectin B chains, which enable the rapid internalization of the toxin into the cell. For this reason, many type 2 RIPs are very cytotoxic, ricin, volkensin and stenodactylin being the most toxic ones. From the caudex of

Identifiants

pubmed: 33499082
pii: toxins13020081
doi: 10.3390/toxins13020081
pmc: PMC7912562
pii:
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Protein Synthesis Inhibitors 0
Ribosome Inactivating Proteins, Type 2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondazione CARISBO
ID : Project 2019.0539
Organisme : (Consejería de Educación, Junta de Castilla y León) to the GIR ProtIBio
ID : Grant VA033G19
Organisme : Pallotti Legacies for Cancer Research
ID : no

Références

Toxins (Basel). 2017 Oct 12;9(10):
pubmed: 29023422
FEBS Lett. 2004 Apr 9;563(1-3):219-22
pubmed: 15063752
J Neurosci Methods. 2000 Nov 15;103(1):73-82
pubmed: 11074097
Phytochemistry. 2007 Mar;68(6):767-76
pubmed: 17258249
Toxicon. 2007 Jul;50(1):94-105
pubmed: 17434551
Molecules. 2016 Nov 26;21(12):
pubmed: 27898041
Nucleic Acids Res. 1997 Feb 1;25(3):518-22
pubmed: 9016590
Mini Rev Med Chem. 2004 Jun;4(5):523-43
pubmed: 15180509
Toxicon. 2005 Nov;46(6):658-63
pubmed: 16165179
FEBS Lett. 1997 May 26;408(3):355-9
pubmed: 9188793
Toxins (Basel). 2019 Jun 18;11(6):
pubmed: 31216687
J Biochem. 2000 Nov;128(5):883-9
pubmed: 11056402
Int J Biochem Cell Biol. 2009 May;41(5):1055-61
pubmed: 18935973
Int J Mol Sci. 2013 Jul 25;14(8):15532-45
pubmed: 23892598
Toxins (Basel). 2017 Mar 29;9(4):
pubmed: 28353660
Front Plant Sci. 2018 Feb 09;9:146
pubmed: 29479367
Planta. 2015 Feb;241(2):421-33
pubmed: 25326773
J Biol Chem. 1988 Jun 25;263(18):8735-9
pubmed: 3288622
Toxins (Basel). 2015 Jan 09;7(1):49-65
pubmed: 25584427
Biomedicines. 2016 Jun 01;4(2):
pubmed: 28536379
Toxins (Basel). 2017 Oct 27;9(11):
pubmed: 29076988
Front Pharmacol. 2020 May 08;11:630
pubmed: 32457623
Toxins (Basel). 2018 Apr 18;10(4):
pubmed: 29669991
Toxins (Basel). 2013 Oct 07;5(10):1698-722
pubmed: 24105401
Biochem J. 1978 Aug 15;174(2):491-6
pubmed: 708401
J Biol Chem. 1987 Apr 25;262(12):5908-12
pubmed: 3571242
Curr Pharm Des. 2014;20(42):6584-643
pubmed: 25341935
Phytomedicine. 2016 Jan 15;23(1):32-41
pubmed: 26902405
Virulence. 2013 Nov 15;4(8):774-84
pubmed: 24071927
Toxins (Basel). 2017 May 30;9(6):
pubmed: 28556822
J Biol Chem. 2002 Apr 19;277(16):13709-16
pubmed: 11825901
Drug Discov Today. 2012 Jul;17(13-14):774-83
pubmed: 22484096
Toxins (Basel). 2020 Mar 09;12(3):
pubmed: 32182799
Neurotoxicology. 2007 May;28(3):637-44
pubmed: 17386942
Anal Biochem. 1977 Oct;82(2):362-71
pubmed: 20815
Int J Biochem Cell Biol. 2008;40(12):2880-8
pubmed: 18611444
Front Pharmacol. 2019 May 08;10:486
pubmed: 31139079
Toxins (Basel). 2019 Aug 01;11(8):
pubmed: 31374990
Toxins (Basel). 2019 Jun 06;11(6):
pubmed: 31174319
J Exp Bot. 2005 Jun;56(416):1675-84
pubmed: 15863448
J Neurosci Methods. 1991 Nov;40(1):17-29
pubmed: 1795550
Molecules. 2016 Nov 18;21(11):
pubmed: 27869738
J Biol Chem. 1985 Nov 25;260(27):14589-95
pubmed: 3932357
J Immunol Methods. 1992 Oct 19;155(1):57-63
pubmed: 1401966
Toxins (Basel). 2015 May 08;7(5):1556-615
pubmed: 26008228
Biochim Biophys Acta. 2016 Jun;1860(6):1256-64
pubmed: 26971856
Toxins (Basel). 2019 Apr 27;11(5):
pubmed: 31035546
FEBS Lett. 2005 Feb 28;579(6):1324-31
pubmed: 15733836
Appl Microbiol Biotechnol. 2020 May;104(10):4211-4226
pubmed: 32193575
J Biomed Sci. 2016 Jul 20;23(1):54
pubmed: 27439918
Biochim Biophys Acta. 2010 Dec;1800(12):1276-82
pubmed: 20933061
Biochemistry. 1974 Jan 1;13(1):196-204
pubmed: 4202710

Auteurs

Massimo Bortolotti (M)

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, General Pathology Section, Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.

Stefania Maiello (S)

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, General Pathology Section, Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.

José M Ferreras (JM)

Department of Biochemistry and Molecular Biology and Physiology, Faculty of Sciences, University of Valladolid, E-47011 Valladolid, Spain.

Rosario Iglesias (R)

Department of Biochemistry and Molecular Biology and Physiology, Faculty of Sciences, University of Valladolid, E-47011 Valladolid, Spain.

Letizia Polito (L)

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, General Pathology Section, Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.

Andrea Bolognesi (A)

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, General Pathology Section, Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH